High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
Abstract Background α3β1 integrin is a promising cancer biomarker and drug target. We previously identified a 9-amino-acid cyclic peptide LXY30 for detecting α3β1 integrin on the surface of live tumor cells. This study was undertaken to characterize LXY30 in the detection, cellular function, imaging...
Main Authors: | Wenwu Xiao, Weijie Ma, Sixi Wei, Qianping Li, Ruiwu Liu, Randy P. Carney, Kevin Yang, Joyce Lee, Alan Nyugen, Ken Y. Yoneda, Kit S. Lam, Tianhong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-06-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-019-0740-7 |
Similar Items
-
Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer
by: Wenwu Xiao, et al.
Published: (2019-07-01) -
Integrin-Linked Kinase Is a Novel Therapeutic Target in Ovarian Cancer
by: Michael A. Ulm, et al.
Published: (2020-11-01) -
Integrin Crosstalk Contributes to the Complexity of Signalling and Unpredictable Cancer Cell Fates
by: Ivana Samaržija, et al.
Published: (2020-07-01) -
The Association of Integrins β3, β4, and αVβ5 on Exosomes, CTCs and Tumor Cells with Localization of Distant Metastasis in Breast Cancer Patients
by: Evgeniya S. Grigoryeva, et al.
Published: (2023-02-01) -
Chemokines and the signaling modules regulating integrin affinity
by: Alessio eMontresor, et al.
Published: (2012-05-01)